SCHEMBL9707617

SCHEMBL9707617

CC(C)Cn1c(=O)c2c(nc(C3CCCCC3)n2Cc2ccc(-c3ccccc3-c3nnn[nH]3)cc2)n(C)c1=O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.43
MEN1 O00255 1/20 0.43
RAB9A P51151 1/20 0.40
AGTR1 P30556 2/20 0.40
AGTR2 P50052 2/20 0.40
MAPK1 P28482 3/20 0.39
TSHR P16473 2/20 0.39
TP53 P04637 1/20 0.39
HSD17B10 Q99714 1/20 0.39
NPSR1 Q6W5P4 2/20 0.39
LMNA P02545 1/20 0.39
POLB P06746 1/20 0.39
BLM P54132 1/20 0.39
CTDSP1 Q9GZU7 1/20 0.39
ADORA3 P0DMS8 1/20 0.38
ADORA2A P29274 1/20 0.38
ADORA2B P29275 1/20 0.38
ADORA1 P30542 1/20 0.38
DPP4 P27487 1/20 0.38
ALDH1A1 P00352 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9707524 0.94 KMT2A (0.44) KMT2AAGTR1AGTR2MAPK1TSHR
SCHEMBL9708682 0.94 KMT2A (0.41) KMT2AAGTR1AGTR2MAPK1NPSR1
SCHEMBL9707375 0.93 ADORA3 (0.44) KMT2AAGTR1AGTR2ADORA3ADORA2A
SCHEMBL9707786 0.92 PDE5A (0.43) KMT2AAGTR1AGTR2ADORA3ADORA2A
SCHEMBL9708135 0.92 KMT2A (0.43) KMT2AAGTR1AGTR2MAPK1TSHR
SCHEMBL9708427 0.91 KMT2A (0.43) KMT2AMEN1AGTR1AGTR2MAPK1
SCHEMBL9707804 0.91 ADORA2A (0.46) KMT2AAGTR1AGTR2MAPK1TSHR
SCHEMBL9707460 0.91 KMT2A (0.43) KMT2AAGTR1AGTR2MAPK1TSHR
SCHEMBL9708520 0.91 TSHR (0.48) KMT2AAGTR1AGTR2MAPK1TSHR
SCHEMBL9708414 0.91 KMT2A (0.39) KMT2AMEN1AGTR1AGTR2MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1992007852-A1 BIPHENYLALKYL XANTHINE COMPOUNDS FOR TREATMENT OF CARDIOVASCULAR DISORDERS G.D. SEARLE & CO. (US) 1992-05-14 WO disclosed